Webinar | October 10, 2019

Implementing A Fully Single-Use, Integrated mAb Biosimilars Purification Platform For Next Generation Manufacturing

1000L-scale implementation of fully connected, disposable, advanced DSP platform for next generation mAb production.

Within the biopharmaceutical industry, there is a significant shift toward higher productivity processes resulting in improved economics without compromising robustness. Therefore, integrated continuous production technologies are of greatest interest. 

Next Generation Biopharmaceutical Downstream Process is a European-funded collaborative project that aims at implementing a fully integrated manufacturing platform for biosimilar mAb based on continuous chromatography, in combination with single-use disposable technologies for all unit operations of DSP on pilot/small production scale together with incorporation of advanced analytical tools.

In this webinar, you will learn:

  • new DSP purification template producing > 3.3 kg of mAb in 2.5 days in less than 30m²
  • proof of concept for the mAb manufacturing of tomorrow

Need More Information? Just Ask.

Click the button below to directly contact the supplier. Use it to:

  • Ask a question.
  • Request more detailed information or literature.
  • Discuss your current project/application.
  • Request a quote.
  • Locate a distributor in your area.
  • Schedule a demo.
Request Info
  Free Bioprocess Online Newsletter

MilliporeSigma